Sanbio, exclusive distributor of the Benelux!
As a biotechnology company, BDR is focused on researching, developing, producing and selling in vitro diagnostic products for human diagnostics (CE-IVD). BDR is specialized in Real Time PCR (qPCR), fragment analysis (QF-PCR) and NGS technologies, and their team are experts in support for the diagnosis of pathologies associated to HLA alelles and rare genetic disorders.
The Adellgene product line of BDR offers CE-IVD marked solutions for the diagnosis of Triplet Repeat Disorders by fragment analysis. This technology, where DNA is amplified by conventional PCR and separated by capillary electrophoresis, allows to quantify the number of triplet repeats in a DNA sample to detect and classify these specific genetic disorders. This product line is focused on rare diseases, such as the Fragile X syndrome, Friedreich’s Ataxia disorder, Myotonic Dystrophy, Spinocerebellar Ataxia disorder and Huntington disease.
The Genvinset product line of BDR offers CE-IVD kits for the detection of several specific target genes, based on qPCR technology. These include the detection of SNPs that are related to genetic disorders in genes such as CFTR, Factor V, PAI-1, MTHFR among others. Also, this product line offers a broad range of detection kits for specific disease and treatment associated HLA alleles. For a complete overview, please visit the BDR product overview page.
